The Global Rosuvastatin Market is valued to grow at a healthy CAGR of 3.5% over the forecast period 2020-2026. Factors like increasing prevalence of obesity and other lifestyle related disorders, availability of generic products, development of health care and infrastructure coupled with increasing R&D investments are propelling the market growth.
Get Sample Report@ https://dataintelo.com/request-sample/?reportId=77571
Rosuvastatin is a drug inhibitor which reveals pharmacokinetic and pharmacologic properties. From the clinical perspective, rosuvastatin serves as a major drug in the prevention of cardiovascular disease. Lifestyle related disorders and drug therapy for controlling hypertension, dyslipdemia and diabetes has a high impact on society. In fact, many findings have proven that the drop in cholesterol levels reduces coronary conditions owing to low baseline. On contrary, rosuvastation successfully demonstrates a decrease in triglyceride concentration as compared with other statins with patients having a high baseline for cholesterol.
DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.
Name: Alex Mathews
Address: 500 East E Street, Ontario,
CA 91764, United States.
Phone No: USA: +1 909 545 6473 | IND: +91-7000061386